Telephone: +44 (0)1223 750638
The 'must attend session' (11:15 to 12:15) at this year's Genesis Conference at the QEII Conference Centre, London.
So where do you go when your pipeline dries up and your products are going off patent? What ‘value add’ can you bring to your organisation? What areas could you, or should you, explore? To give you a clue, consider GSK exploring the possibility of developing products from Traditional Chinese Medicines (TCMs).
The Directors of GRS are deeply shocked and saddened by the sudden death of Andy King. Greer Deal knew Andy almost from the very beginning of her career in the life sciences over 20 years ago. She and Bobby Deal grew to know him more personally, however, when they officially launched Global Regulatory Services (GRS) in May 2008. He was incredibly supportive of GRS and more than willing to share his experiences and knowledge of business with Bobby and Greer. We had long-term plans to work with Andy but, whilst we were busy making plans, li
8 November 2013: The Directors of Global Regulatory Services (GRS) were directly involved in the €1.1m European Union (EU) research project examining Good Practice in Traditional Chinese Medicine Research (GP-TCM) in the Post-Genomic Era. Greer Deal was the Deputy Coordinator of The Seventh Work Package (Commercial R&D) of the FP7 EU-China GP-TCM Consortium. Both Directors were very actively involved in The Seventh Work Package (WP7). The aim of WP7 was:
4 November 2013 – Cambridge, UK: Global Regulatory Services (GRS) is now a Partner of One Nucleus. Through an innovative collaboration under the One Nucleus Partner Programme, GRS will be delivering a new training course during 2014 entitled “An Introduction to Regulation in New Medicines and Healthcare Products”. The course content will be developed and delivered by GRS, enabling One Nucleus members to provide their staff with a firm understanding of the core business. C
GRS are delighted to be hosting the Natural Products Stream at the annual Genesis conference again. It's being held at the QEII Conference Centre, Westminster, London on Thursday 12th December.
This year the format is changing with a couple of keynote speakers sharing their knowledge and experience, followed by a panel debate comparing the regulatory pathways between Canada and the UK with input from a representative from Academia.
GRS will be presenting at 13:15 on the subject of Herbal Product Regulations. Herbals are one of the few products where so many EU regulations could apply: food supplement with claim, medical food, cosmetic, Traditional Herbal Medicines Registration Scheme (THMRS), medical device, medicine etc. In some cases, clinical trials are required and in others they are not, although safety testing is always a must.
Will revision of the EU Medical Device Directive mean more trials at more cost but more reward?"
I was delighted to be asked to speak for a few minutes at this event about Global Regulatory Services' (GRS) membership to the Cambridge Network. GRS has been a member since the company was officially launched in May 2008 and we've always found the Cambridge Network team to be so supportive and informative. The networking events which GRS representatives have attended have either been directly relevant or let's s
11 June 2013, Hamilton House, London: Greer Deal, Director of Global Regulatory Services (GRS) is Chairing the "Bio-medical futures in the corridor" session at this prestigious event.
|Copyright © 2013 GRS All Rights Reserved||
Global House, Painters Lane, Sutton, Ely,
Cambridgeshire, CB6 2NS, UK
Telephone: +44(0)1223 750638